Stocks · Health care · Pharmaceutical Preparations

MANNKIND CORP

MNKD Clue Score45

United States Fiscal year ends December CIK 0000899460 Results filed 5 Nov 2026

Add to watchlist

What the insiders did Net buying

By person

13 insiders · 15 transactions

Insider

Role

Bought

Sold

Net

Holding

Of company

Worth

Change

Michael Castagna

Chief Executive Officer

$259.00K (1)

$1.25M (4) scheduled

−$990.29K

2,433,779

0.7569%

$8.01M

+10.4%

David Thomson

EVP Genl Counsel & Secretary

—

$930.75K (3) scheduled

−$930.75K

797,554

0.2480%

$2.62M

−3.9%

Steven B. Binder

Director

—

$683.70K (5) scheduled

−$683.70K

713,258

0.2218%

$2.35M

−33.7%

Stuart A Tross

Chief People & Workpl Officer

—

$297.55K (1) scheduled

−$297.55K

1,058,142

0.3291%

$3.48M

+2.6%

Sanjay R Singh

EVP Technical Operations

—

$94.45K (1) scheduled

−$94.45K

478,966

0.1490%

$1.58M

+23.6%

Burkhard Blank

EVP Chief Medical Officer

—

—

—

460,791

0.1433%

$1.52M

−5.2%

Lauren M Sabella

EVP Operations

—

—

—

349,841

0.1088%

$1.15M

−7.5%

Dominic Marasco

Pres, Endocrine Business Unit

—

—

—

343,398

0.1068%

$1.13M

+6,610%

Christopher B Prentiss

Chief Financial Officer

—

—

—

318,668

0.0991%

$1.05M

+32.4%

Ajay Ahuja

Chief Medical Officer

—

—

—

318,200

0.0990%

$1.05M

—

Anthony C Hooper

Director

—

—

—

236,153

0.0734%

$776.94K

+34.1%

Ronald J Consiglio

Director

—

—

—

132,342

0.0412%

$435.41K

+8.2%

James Samuel Shannon

Director

—

—

—

64,635

0.0201%

$212.65K

+22.8%